Wisp logo

Wisp Review

7.1
★★★★☆3.6/5

Semaglutide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: branded injectables plus a sublingual semaglutide alternative

Wisp scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide · sublingual

$225/mo

Price checked on Wisp's site,

What the monthly price covers

Medication

Included

Provider visits

Not stated

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Wisp is a US telehealth provider whose weight care vertical offers brand-name Wegovy (injectable and oral) and Zepbound alongside a compounded sublingual semaglutide drops formulation at $225/month. Reviews are completed by board-certified providers within 24-72 hours. Wisp is LegitScript certified.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedBrandOral OptionSemaglutideWegovyZepboundLegitScript Verified

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Wisp

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Wisp logo
3.6 / 5
Our editorial rating
Visit Wisp →

from $225/mo · no insurance needed

Wisp at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Wegovy, Zepbound
Starting price
$225/mo
What's included
Medication · Shipping
FDA status
No FDA warning letter on record

How we scored Wisp

Each dimension is scored algorithmically from Wisp'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.3/10

At $225/mo, Wisp runs about 26% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

8.3/10

Wisp offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.3/10

Online intake and platform experience; 7 platform features disclosed.

Trust & Safety15%

7.4/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.2/10

Wisp's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.0/10

Wisp provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Wisp review

Last checked November 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$73–$225/mo across 2 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Wisp

We walked Wisp's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Explore care options and tell them your goals (review eligibility).
  2. 2Complete the medical intake form; licensed providers review medical history.
  3. 3Connect with your specialist for a treatment plan.
  4. 4Same-day local pickup or free delivery; monthly provider check-ins.
Price shown before you start
  • Product pages show monthly prices before intake ($225/mo compounded semaglutide, $99/mo Zepbound, $99 weight-care consult).
  • 'The lowest dosage will be added to your cart; our provider will review and adjust as needed.'
  • Prescriptions sent within 3 hours of completing intake plus a phone or video chat when necessary. Video is conditional, not required.
  • Primarily a sexual/reproductive and women's health telehealth that also runs a weight-care line.

Wisp customer support

Hours
9:30a-6:30p EST M-F

GLP-1 medications Wisp offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

Compounded sublingual semaglutide drops 15mLCompounded
$225/mo
semaglutide

A separate Weight Care Consult is $99. Wisp does not offer compounded tirzepatide; brand Zepbound is prescribed separately.

Metabolic Support & GLP-1 Boost capsules (adjunct supplement, not a prescription GLP-1)supplement subscription
$73/mo

A monthly supplement subscription, not a prescription GLP-1 medication.

Ready to get started?

Plans and promotions change often, so check Wisp's current pricing and active discounts before you decide.

See Wisp pricing →

What we like

  • Broad GLP-1 menu: branded Wegovy (injectable and oral) and Zepbound plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Watch-outs

  • Wisp's own page says sublingual compounded semaglutide hasn't been tested in humans; only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Wisp's verdict: a brand-name menu with one candid experiment attached

Wisp is one of the few telehealth companies that will sell you an FDA-approved injectable and, on the very same weight-care page, tell you in plain language that its own signature compounded product hasn't been tested in a human body. That candor is the most useful thing about this provider. If you want real GLP-1 medication with a clear paper trail, Wisp can route you to branded semaglutide (Wegovy) and tirzepatide-based Zepbound, with Saxenda as a third option. If you're shopping specifically for the cheap, needle-free sublingual drops it advertises, read the caveats before you get attached to the idea. Compounded tirzepatide by injection is another route; WeightRx sells it on prepaid 6- and 12-month plans.

What you get for the money

The headline weight-care product is a compounded sublingual semaglutide drops formulation (a 15mL bottle) at $225 a month. That price includes the medication and free, discreet delivery to your door. There's no separate shipping charge layered on top. For context, the category median across providers we track sits around $179 a month, so Wisp's drops land on the higher side of compounded pricing despite being a less-proven format.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

Wisp does not run a first-month teaser rate on the drops. The price you see is the price you pay from month one, which at least keeps it free of bait-and-switch promo math. A few adjacent products carry their own separate fees you should budget for. The weight-care consult is priced in the high two figures per month. An optional metabolic-support and 'GLP-1 boost' capsule supplement starts in the mid-two-figures monthly (this is a supplement, not a prescription GLP-1, so don't confuse the two). And a metformin-for-PCOS option sits in the low-two-figure range.

The medications, and how they're dispensed

Wisp's weight vertical is broader than most compounded-only shops. The /shop/weight-care page lists branded Wegovy, Zepbound, and Saxenda (FDA-approved injectables) alongside the compounded sublingual drops. Wisp has also recently added 'Oral Wegovy' to the menu, though it doesn't publish a price for it, so you'd need to start an intake to learn the cost. The branded injectables are likewise listed without public prices, which is a friction point: you can't comparison-shop the brand options up front.

Intake is asynchronous. A board-certified provider reviews your case and gets back to you within 24 to 72 hours, then the lowest starting dose is added to your cart and the clinician follows up with a plan tailored to you. Two clinicians are named, Dr. Shannon Chatham (DO) and Andrea Sleeth (WHNP-BC), which is more transparency on the medical side than many competitors offer.

The sublingual drops: Wisp's differentiator, and its biggest asterisk

This is where Wisp earns both credit and caution. The drops are the product it's clearly betting on, and the company is unusually straight about their limits. Wisp's own product page states, verbatim, that while lab tests using human-derived tissues suggest the formulation may begin working within 15 to 30 minutes, “it has not yet been tested within the human body,” that “because of this, the effectiveness of this formulation in patients may vary,” and that compounded drugs “are not FDA approved and do not undergo FDA safety, efficacy, or quality review.”

That is more cautious labeling than the compounded telehealth segment usually bothers with. The flip side is just as important: the entire efficacy case for GLP-1 weight loss (the trial data showing sustained results) comes from the injectables, not from sublingual drops. So you're paying a mid-range monthly rate for a delivery format with no human bioavailability data behind it. The saving grace is that if the drops underwhelm you, Wisp can pivot you to a branded injectable without changing providers.

  • Best case: you want a needle-free entry point, you understand it's experimental, and you like having branded injectables one message away.
  • Worst case: you assume sublingual drops work as well as a Wegovy shot. By Wisp's own admission, they have not been shown to.

Trust, safety, and oversight

Wisp is LegitScript certified, with the seal in the site footer. That is a baseline signal that the pharmacy operation passed a third-party legitimacy review. Wisp has no FDA warning letter against it; it did not appear in the large September 2025 sweep of 50-plus companies or the February 2026 telehealth sweep, and there's no litigation against it. Combined with the two named, credentialed clinicians and the unusually honest product copy, the oversight picture is solid for a compounding-adjacent telehealth brand.

The gaps are in disclosure, not safety. Wisp does not name its compounding pharmacy partners, and it does not publish the list of states it serves, so you'll have to confirm during intake that it operates where you live. Those omissions are why this provider sits a notch below the top in our scoring methodology.

Who should choose Wisp, and who should skip it

  • Choose it if: you want access to branded Wegovy, Zepbound, or Saxenda from a LegitScript-certified provider with named clinicians, and you value a company that tells you the truth about what's unproven.
  • Choose it if: you're curious about a sublingual alternative and you're going in with clear eyes about its experimental status.
  • Skip it if: the sublingual drops are your main draw and you expected injectable-level results. The data isn't there.
  • Skip it if: you need up-front pricing on the branded injectables before you'll commit, or you require a published list of covered states.

Bottom line

Wisp is an honest operator in a segment that often isn't. Its strength is the combination of FDA-approved injectables, a LegitScript certification, named providers, and product copy that refuses to oversell. Its compounded sublingual drops at $225 a month are the hook, but they're also the weakest part of the value proposition: an unproven format at a not-cheap price. The smart way to use Wisp is to treat the drops as optional and the branded-injectable pathway as the main event. Just be ready to start an intake to see brand pricing, and to confirm your state is covered before you count on it.

The Bottom Line

Wisp scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.1/10Best for: branded injectables plus a sublingual semaglutide alternativeFrom: $225/mo

Ready to start with Wisp?

From $225/mo. See current pricing and start your online intake.

Wisp might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If a lower monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Wisp vs…

Wisp scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Wisp is a US telehealth provider with a weight care vertical that offers both branded GLP-1 injectables and a compounded sublingual semaglutide option. Consultations are completed online by board-certified providers, typically within 24 to 72 hours. Wisp is LegitScript certified.
Wisp's weight care menu includes brand-name Wegovy and Zepbound, an oral Wegovy option, and a compounded sublingual semaglutide drops formulation at $225 per month. It also sells a Metabolic Support & GLP-1 Boost capsule supplement, which is a subscription supplement and not a prescription GLP-1 medication. A licensed clinician determines which option, if any, is appropriate for you.
Wisp is unusually candid about this: its own product page states that the sublingual formulation has not yet been tested within the human body, so its effectiveness in patients may vary. Only the branded injectables (Wegovy, Zepbound, Saxenda) have FDA efficacy data. Compounded drugs are not FDA-approved and do not undergo FDA safety, efficacy, or quality review.
The compounded sublingual semaglutide drops are listed at $225 per month, a weight care consult starts at $99, and the Metabolic Support & GLP-1 Boost supplement starts at $73 per month. The branded injectables (Wegovy, Zepbound) and oral Wegovy are listed without public prices, so you would confirm those costs during intake. Medication ships free.
You complete an online intake, and a board-certified provider reviews it, generally within 24 to 72 hours, to decide whether treatment is appropriate. If prescribed, your medication ships free in discreet packaging, with local pickup available for some products. Ongoing care is handled online.
Wisp is LegitScript certified and lists named board-certified providers such as Dr. Shannon Chatham, DO, and Andrea Sleeth, WHNP-BC. It is transparent about the limits of its compounded sublingual product. Its full list of states served was not published at our last review, and pharmacy partners are not named.
When we last checked (June 2026), Wisp offered code SUNNY20 (20% off your first order). Apply it on Wisp's own checkout via the link on this page, and ignore third-party sites listing other "Wisp codes", which are typically fake.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Wisp. The concerns our review flags: Wisp's own page says sublingual compounded semaglutide hasn't been tested in humans; only the injectables have FDA efficacy data; pharmacy partners not named; states served not listed publicly. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Wisp review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.

See Wisp's current pricing

Plans from $225/mo. Start the online intake to check eligibility and today's price.